行情

CVM

CVM

CEL SCI
AMEX

实时行情|Nasdaq Last Sale

11.59
+0.44
+3.95%
交易中 13:16 09/21 EDT
开盘
11.24
昨收
11.15
最高
11.77
最低
11.21
成交量
21.77万
成交额
--
52周最高
40.91
52周最低
7.08
市值
4.99亿
市盈率(TTM)
-13.5050
分时
5日
1月
3月
1年
5年
Cel-Sci Corporation 申请了名为“用于疫苗接种和治疗 2019-nCoV 感染的新型肽”的美国专利
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=6592&p=132&f=G&l=50&d=PG01&S1=20210902.PD.&OS=PD/20210902&RS=PD/20210902
Benzinga · 09/02 13:58
CVM：Primum Non Nocere
By John Vandermosten, CFA NYSE:CVM READ THE FULL CVM RESEARCH REPORT
Benzinga · 08/29 09:21
午间市场更新：monday.com 在第二季度业绩强劲后跳涨； Kubient 股价暴跌
Midway through trading Tuesday, the Dow traded down 0.81% to 35,336.88 while the NASDAQ fell 0.89% to 14,661.86. The S&P also fell, dropping 0.65% to 4,450.54.
Benzinga · 08/17 16:11
CEL-SCI 第三季度每股收益（0.25 美元）同比上涨（0.27 美元）
CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.25) per share. This is a 7.41 percent increase over losses of $(0.27) per share from the same period last year.
Benzinga · 08/16 13:07
分析 CEL-SCI 的异常期权活动
On Tuesday, shares of CEL-SCI (AMEX:CVM) saw unusual options activity. After the option alert, the stock price moved up to $9.22.
Benzinga · 08/10 14:49
了解 CEL-SCI 的异常期权活动
CEL-SCI (AMEX:CVM) shares experienced unusual options activity on Monday. The stock price moved down to $7.68 following the option alert.
Benzinga · 07/19 16:41
不寻常的期权活动洞察：CEL-SCI
Shares of CEL-SCI (AMEX:CVM) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $9.35.
Benzinga · 07/12 15:51
CVM：数据已发布
By John Vandermosten, CFA NYSE:CVM READ THE FULL CVM RESEARCH REPORT Data Readout From the IT MATTERS Trial On June 28, 2021, CEL-SCI Corporation (NYSE:CVM) reported selected data from the IT-MATTERS trial. While details for the primary endpoint were not p...
Zacks Small Cap Research · 07/08 16:16
更多
财务预测
实际值（美元）
预测值（美元）
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解CVM最新的财务预测，通过CVM每股收益，每股净资产，每股现金流等数据分析CEL SCI近期的经营情况，然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明：分析师观点仅供投资者决策参考，不构成任何买卖投资建议。

目标价格预测
分析师预测CVM价格均价为12.00，最高价位12.00，最低价为12.00。
EPS
机构持股
总机构数: 69
机构持股: 585.04万
持股比例: 13.60%
总股本: 4,302.81万
类型机构数股数
增持
19
265.68万
建仓
30
49.35万
减持
4
17.75万
平仓
3
24.38万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
+0.50%
制药与医学研究
+0.77%
高管信息
Chief Executive Officer/Director/Treasurer
Geert Kersten
Senior Vice President/Secretary
Patricia Prichep
Senior Vice President
John Cipriano
Senior Vice President
Daniel Zimmerman
Chief Scientific Officer
Eyal Talor
Independent Director
Bruno Baillavoine
Independent Director
Robert Watson
Independent Director
Peter Young
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
CVM 简况
CEL-SCI Corp is a clinical-stage biotechnology company. The Company is focused on activating the immune system to fight cancer and infectious diseases. The Company is engaged in research and developing the treatments for the cancer and other diseases by using the immune system. The Company’s lead investigational therapy Multikine (Leukocyte Interleukin, Injection) is in a pivotal Phase 3 clinical trial. Its Multikine is an investigational immunotherapy under development for the potential treatment of certain head and neck cancers. The Company using its Ligand Epitope Antigen Presentation System (LEAPS) technology platform is investigating product candidates include CEL-2000 and CEL-4000. CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis. It is also investigating LEAPS COVID-19 conjugates as a potential treatment of coronavirus (COVID-19) in hospitalized and at-high-risk patients at the University of Georgia’s (UGA) Center.

微牛提供CEL-SCI Corporation(AMEX-CVM)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CVM股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CVM股票基本功能。